Kim Kelderman is a seasoned executive who currently holds the position of President and CEO at Bio-Techne Corporation, a global life sciences company that develops, manufactures, and sells products for the research and clinical diagnostic markets. Prior to his current role, Kelderman served as the President of Diagnostics and Genomics at Bio-Techne, where he played a pivotal role in driving the company's growth and expansion in these key areas. With a strong background in the life sciences industry, Kelderman has consistently demonstrated his ability to lead and innovate, making him an invaluable asset to the organization. Before joining Bio-Techne, Kelderman held various leadership positions at other prominent life sciences companies. His professional journey includes significant roles at companies such as Life Technologies, where he served as the President of Genetic Sciences, and at Invitrogen, where he was the President of Molecular Biology Systems. Throughout his career, Kelderman has been instrumental in driving strategic initiatives, fostering innovation, and building high-performing teams. His expertise in diagnostics and genomics has been particularly valuable in helping Bio-Techne navigate the rapidly evolving landscape of life sciences research and clinical diagnostics. As President and CEO of Bio-Techne, Kelderman is responsible for overseeing the company's overall strategy and operations. Under his leadership, Bio-Techne has continued to expand its portfolio of cutting-edge products and services, solidifying its position as a leader in the life sciences industry. Kelderman's vision and strategic direction have been crucial in driving the company's growth and success, and his commitment to innovation and excellence has helped Bio-Techne maintain its reputation as a trusted partner for researchers and clinicians worldwide.